Carle Illinois College of Medicine has named Dr. Adil Haider as its first Chief Artificial Intelligence Officer. In this newly created role, Haider will lead the strategic vision, development, and responsible deployment of AI across CI MED. He will be responsible for advancing AI-enabled medical education, translational research, and clinical innovation.

In addition to his duties at CI MED, Haider will serve as medical director for research informatics at Carle Foundation Hospital, strengthening alignment between academic innovation and real-world clinical practice. In this dual role, he will help integrate advanced informatics and AI-driven tools to enhance care delivery, clinical efficiency, and the patient experience across the Carle Health system.

At the University of Illinois, Haider will also serve as a visiting professor at the Siebel School of Computing and Data Science within the Grainger College of Engineering, helping to deepen collaboration between medicine, engineering, and data science.

On LinkedIn, Haider described these roles as “a unique and meaningful opportunity to work at the intersection of clinical care, academic leadership, and responsible innovation.”

Haider previously served for more than six years as dean of Aga Khan University Medical College in Pakistan, where he quadrupled research funding, achieved a top 100 global ranking, and earned multiple international accreditations, including ACGME-International and AACME. He also served as Kessler Director of the Center for Surgery and Public Health at Brigham and Women’s Hospital and Harvard Medical School and spent nearly a decade at Johns Hopkins University as a trauma surgeon and director of the Center for Surgical Trials and Outcomes Research.

He is the founder of two health technology companies, including Boston Health AI, an AI-driven clinical intelligence platform operating in the United States, the United Arab Emirates, and Pakistan. Haider continues to oversee ongoing academic and editorial work, including roles at Aga Khan University and as Deputy Editor at JAMA Surgery, reflecting his commitment to responsible innovation and aligning technology with real-world clinical needs.